细胞周期相关蛋白cyclin D1、p53和p21在食管鳞癌中的表达改变及其病理学意义
收稿日期: 2010-01-15
修回日期: 2010-03-14
网络出版日期: 2010-05-15
基金资助
国家科技支撑计划(编号：2006BAI02A14)和863计划重大专项(编号：2006AA02A403)资助
Expression of cell cycle related proteins cyclin D1, p53 and p21 in esophageal squamous cell carcinoma
Received date: 2010-01-15
Revised date: 2010-03-14
Online published: 2010-05-15
食管鳞状细胞癌(Esophageal squamous cell carcinoma, ESCC)是我国常见的恶性肿瘤之一, 虽然临床诊治手段正逐步改进, 但中晚期患者5年生存率仍然很低。目前认为细胞周期调控异常与肿瘤发生发展关系密切, 然而相关周期调节蛋白在食管癌患者中的表达改变、临床意义及其应用价值还没有明确结论。文章应用组织微阵列联合免疫组织化学技术(TMA-IHC), 对148例食管鳞癌组织标本中细胞G1/S期调控蛋白cyclin D1、p53和p21WAF1/Cip1的表达进行检测, 分析其与临床病理参数之间的相关性。结果显示, cyclin D1与p53蛋白在食管癌细胞中表达升高, p53表达阳性率与区域淋巴结转移显著相关(P = 0.001)。p21WAF1/Cip1蛋白在肿瘤组织中表达降低, 且p21WAF1/Cip1表达阴性患者的术后生存时间显著短于表达阳性的患者(P = 0.001)。多因素生存分析显示p21WAF1/Cip1是一个独立的预后因素(相对危险度为0.418, P<0.001)。微阵列比较基因组杂交(array-CGH)检测进一步表明45.4%的食管癌患者存在cyclin D1基因扩增。以上结果提示食管鳞癌中存在细胞周期G1/S期调控异常, p21WAF1/Cip1蛋白可能是一个有应用价值的预后因子。
林德晨，史志周，薛丽燕，陈微，徐昕，韩亚玲，吕宁，王明荣 . 细胞周期相关蛋白cyclin D1、p53和p21在食管鳞癌中的表达改变及其病理学意义[J]. 遗传, 2010 , 32(5) : 455 -460 . DOI: 10.3724/SP.J.1005.2010.00455
Dysregulation of cell cycle control, especially G1/S phase transition, is implicated in the pathogenesis of most human cancers, including esophageal squamous cell carcinoma (ESCC). However, the clinicopathological significance of aberrant expression of G1/S phase-related proteins in ESCC remains unclear. In the present study, cyclin D1, p21WAF1/Cip1 and p53 protein expression were examined in 148 ESCC cases using immunohistochemistry combined with tissue microarray. We then analyzed the correlations between their expression and clinicopathological parameters and found that overexpression of p53 was associated with lymph node metastasis (P = 0.001). p21WAF1/Cip1 down-regulation was an independent prognostic factor by multivariate analysis (RR = 0.418, P <0 .001). Further more, array-CGH results revealed that cyclin D1 gene was amplified in 45.4% of ESCC patients. This study confirms that dysregulation of G1/S related genes is common in ESCC and reduced expression of p21WAF1/Cip1 protein can predict shorter overall survival time of patients with ESCC.
[1] Roncalli M, Bosari S, Marchetti A, Buttitta F, Bossi P, Graziani D, Peracchia A, Bonavina L, Viale G, Coggi G. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma. Lab Invest, 1998, 78(9): 1049–1057.
[2] Shao L, Hittelman WN, Lin J, Yang H, Ajani JA, Wu X. Deficiency of cell cycle checkpoints and DNA repair sys-tem predispose individuals to esophageal cancer. Mutat Res, 2006, 602(1–2): 143–150.
[3] Shinohara M, Aoki T, Sato S, Takagi Y, Osaka Y, Koyanagi Y, Hatooka S, Shinoda M. Cell cycle-regulated factors in eso-phageal cancer. Dis Esophagus, 2002, 15(2): 149–154.
[4] Paulson TG, Galipeau PC, Xu L, Kissel HD, Li X, Blount PL, Sanchez CA, Odze RD, Reid BJ. p16 mutation spec-trum in the premalignant condition Barrett's esophagus. PloS One, 2008, 3(11): e3809.
[5] Fang JY, Lu YY. Effects of histone acetylation and DNA methylation on p21( WAF1) regulation. World J Gastro-enterol, 2002, 8(3): 400–405.
[6] Amanullah A, Hoffman B, Liebermann DA. Deregulated E2F-1 blocks terminal differentiation and loss of leuke-mogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A). Blood, 2000, 96(2): 475–482.
[7] Zhang G, Zhou X, Xue L, Quan L, Wang Y, Zhou C, Lu N, Wang Q, Zhu H, Xu N. Accumulation of cytoplasmic beta-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: immunohistochemical study. Pathol Int, 2005, 55(6): 310–317.
[8] Natsugoe S, Nakashima S, Matsumoto M, Xiangming C, Okumura H, Kijima F, Ishigami S, Takebayashi Y, Baba M, Takao S, Aikou T. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clin Cancer Res, 1999, 5(9): 2445–2449.
[9] Mega S, Miyamoto M, Ebihara Y, Takahashi R, Hase R, Li L, Shichinohe T, Kawarada Y, Uehara H, Kaneko H, Hashimoto H, Murakami Y, Itoh T, Morikawa T, Kondo S. Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma. Dis Esophagus, 2005, 18(2): 109–113.
[10] Wei F, Ni J, Wu SS, Liu H, Xu X, Han YL, Cai Y, Zhang JW, Chen XJ, Pang H, Lu N, Ji L, Wu M, Wang MR. Cytogenetic studies of esophageal squamous cell carcinomas in the north-ern Chinese population by comparative genomic hybridiza-tion. Cancer Genet Cytogenet, 2002, 138(1): 38–43.
[11] He YT, Hou J, Qiao CY, Chen ZF, Song GH, Li SS, Meng FS, Jin HX, Chen C. An analysis of esophageal cancer in-cidence in Cixian county from 1974 to 1996. World J Gastroenterol, 2003, 9(2): 209–213.
[12] Pesutic-Pisac V, Punda A, Gluncic I, Bedekovic V, Pranic-Kragic A, Kunac N. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: as-sociation with clinicopathological parameters. Croat Med J, 2008, 49(5): 643–649.
[13] Aaltonen K, Amini RM, Landberg G, Eerola H, Aittomaki K, Heikkila P, Nevanlinna H, Blomqvist C. Cyclin D1 ex-pression is associated with poor prognostic features in es-trogen receptor positive breast cancer. Breast Cancer Res Treat, 2009, 113(1): 75–82.
[14] Ikeguchi M, Sakatani T, Ueta T, Kaibara N. Cyclin D1 expression and retinoblastoma gene protein (pRB) expres-sion in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol, 2001, 127(9): 531–536.
[15] Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K. Concomitant analysis of p16/INK4, cyclin D1, and retino-blastoma protein expression in esophageal squamous cell car-cinoma. Hepatogastroenterology, 2003, 50(53): 1321–1326.
[16] Jang KT, Chae SW, Sohn JH, Park HR, Shin HS. Coex-pression of MUC1 with p53 or MUC2 corr
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:
